Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary interventionUwe Zeymer
Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
EuroIntervention 4:524-8. 2009
..We sought to determine the efficacy of enoxaparin in unselected patients with STEMI treated with primary percutaneous coronary intervention in clinical practice...
Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Ralf Zahn
Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
Catheter Cardiovasc Interv 74:1-8. 2009
..To determine the influence of the side intervened upon on outcomes during carotid artery stenting (CAS)...
[Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]Ralf Zahn
Chefarzt der Medizinischen Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen
Herz 34:211-7. 2009
..However, at least in regions with a high density of invasive centers, such networks should take the investigators' experience and the annual interventional volumes of the participating hospitals into account...
Transcatheter Aortic Valve Implantation in Patients With "Porcelain" Aorta (from a Multicenter Real World Registry)Ralf Zahn
Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen, Germany Electronic address
Am J Cardiol 111:602-8. 2013
..Although differences were found in its frequency among the participating hospitals, the presence of a porcelain aorta was not associated with in-hospital death or stroke...
Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent RegistryRalf Zahn
Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
Clin Res Cardiol 101:709-16. 2012
..To obtain long-term follow-up data of the sirolimus-eluting coronary stent (SES) and to determine factors associated with clinical events and target vessel revascularization (TVR)...
Midventricular form of takotsubo cardiomyopathy as a recurrence 1 year after typical apical ballooning: a case reportOliver Koeth
Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
Cases J 1:331. 2008
..Recurrences of Takotsubo Cardiomyopathy, especially in variant regions of the left ventricle are rareWe describe a midventricular form of Takotsubo Cardiomyopathy as a recurrence 1 year after typical apical ballooning...
Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?Ralf Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Germany
J Am Coll Cardiol 45:1769-74. 2005
..We sought to compare the efficacy of a filter embolic protection device (F-EPD) and a distal occlusive embolic protection device (DO-EPD) in patients undergoing carotid artery stenting (CAS)...
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)Ralf Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Germany
Am J Cardiol 95:1302-8. 2005
..The management of bypass grafts and multiple lesions in 1 session and the presence of multivessel disease were predictors of MACCEs or TVR...
Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent RegistryRalf Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Germany
J Interv Cardiol 23:18-25. 2010
..However, because of safety concerns and frequent "off-label" use data from "real life," registries are necessary to monitor indications and outcome of DES in daily clinical practice...
Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiologyRalf Zahn
Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Germany
Clin Res Cardiol 99:193-7. 2010
..Concerning this pathophysiology, a further TAVI was performed using a second 29-mm CoreValve Revalving system, as a "valve-in-valve" implantation...
Carotid artery stenting in clinical practice results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)R Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 94:163-72. 2005
..However, its feasibility and safety in clinical practice at a broad spectrum of hospitals needs to be determined...
Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Ralf Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstraße 79, 67063 Ludwigshafen, Germany
Clin Res Cardiol 99:809-15. 2010
..To compare characteristics and outcome of patients with re-stenoses after prior carotid artery stenting (CAS) treated with repeat carotid interventions (Re-CI) with CAS for de novo lesions...
Embolic protection devices for carotid artery stenting: better results than stenting without protection?Ralf Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Germany
Eur Heart J 25:1550-8. 2004
..However, CAS itself can cause cerebral ischaemic events. Embolic protection devices (PD) promise to reduce the incidence of these events...
[Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]Ralf Zahn
Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen
Dtsch Med Wochenschr 135:1589-95. 2010
....
Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende KardioR Zahn
Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg Süd, Nurnberg
Heart 94:329-35. 2008
..The formerly observed volume-outcome relation for percutaneous coronary interventions (PCIs) has recently been questioned...
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent RegistryRalf Zahn
Klinikum Swfd, Kardiologie, Nurnberg, Germany
Am Heart J 152:1146-52. 2006
....
Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) RegistryRalf Zahn
Städtisches Klinikum, Med Klinik 8, Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg, 90471 Nürnberg, Germany
Eur Heart J 28:370-5. 2007
..We tried to determine the influence of age on complication rates of carotid artery stenting (CAS)...
The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent RegistryRalf Zahn
Med Klinik 8, Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg Süd, Breslauer Strasse 201, 90471, Nurnberg, Germany
Clin Res Cardiol 96:548-56. 2007
..Due to limited budgets in Germany, no special reimbursement has been given for their use and therefore they were mainly used in selected patients...
Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)R Zahn
Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg, Breslauer Strasse 201, 90471 Nürnberg, Germany
Clin Res Cardiol 96:730-7. 2007
..Glycoprotein II b/IIIa antagonists (GPII b/IIIa-A) lower the periprocedural rate of ischemic events during high risk percutaneous coronary interventions. Their clinical impact on carotid artery stenting (CAS) remains to be determined...
Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent RegistryRalf Zahn
Med Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Clin Res Cardiol 99:99-106. 2010
..Treatment of restenosis following intracoronary brachytherapy (ICB) is still a challenging problem. Implantation of sirolimus-eluting stents (SES) in this setting may be an option to be evaluated...
Survived heart arrest in a 24 year old woman: a late sequel of formerly undiagnosed Kawasaki diseaseRalf Zahn
Med. Klinik 8 Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
Clin Res Cardiol 95:316-8. 2006
Reperfusion therapy for acute ST-elevation and non ST-elevation myocardial infarction: what can be achieved in daily clinical practice in unselected patients at an interventional center?Ralf Zahn
Heart Center, Department of Cardiology, Ludwigshafen, Germany
Acute Card Care 11:92-8. 2009
..The characterization of AMI patients according to this definition is still incomplete...
An unusual cause of dyspnoea and pulmonary hypertension in a patient with a symptom history of 20 years--"Just do it again"Ralf Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Clin Res Cardiol 95:68-71. 2006
Treatment of a large coronary saphenous bypass graft aneurysm by implantation of covered stentsRalf Zahn
Med. Klinik 8, Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
Clin Res Cardiol 95:313-5. 2006
Stent-supported angioplasty versus endarterectomy for carotid artery stenosis: evidence from current randomized trialsR Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063, Ludwigshafen, Germany
Z Kardiol 94:836-43. 2005
..However, the value of CAS is still a matter of debate. Therefore, we performed a metaanalysis of the randomized controlled clinical trials (RCT) on this issue...
In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the ArbeR Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Germany
Heart 91:1041-6. 2005
..To determine the predictors of time between presentation and primary angioplasty and the influence of this delay time on in-hospital mortality in clinical practice...
[Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]R Zahn
Herzzentrum, Kardiologie, Ludwigshafen, Allemagne
Ann Cardiol Angeiol (Paris) 53:36s-39s. 2004
"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher RegistryR Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 93:287-94. 2004
..Therefore, actual clinical practice may be very different to RCT...
Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute R Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 92:847-51. 2003
....
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysisR Zahn
Herzzentrum Ludwigshafen, Kardiologie, Germany
Am Heart J 142:105-11. 2001
..In patients with acute myocardial infarction treated with thrombolysis, longer times to treatment are associated with increasingly worse clinical outcome. This relation may be different for treatment with primary angioplasty...
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial InfarctionR Zahn
Department of Cardiology, Herzzentrum Ludwigshafen, Germany
J Am Coll Cardiol 37:1827-35. 2001
..We sought to determine the effectiveness of primary angioplasty compared with thrombolysis in clinical practice...
Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and thR Zahn
Herzzentrum Ludwigshafen, Dept of Cardiology, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
J Invasive Cardiol 13:367-72. 2001
..There are no data addressing whether this time limit is also justified for treatment with primary angioplasty...
[Interventional therapy of acute myocardial infarction]R Zahn
Kardiologie, Pneumologie, Angiologie und Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
Internist (Berl) 49:1038-46. 2008
..In Germany this goal is achievable almost everywhere. Therefore it is currently the most important task to establish local networks to reach this goal...
Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) RegiR Zahn
Herzzentrum Ludwigshafen
Herz 25:667-75. 2000
..The proportion of transferred patients increased from 1.1% in 1994 to 5.5% in 1998. Contraindications for thrombolysis were the strongest predictor to transfer patients to primary angioplasty...
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction RegistryR Zahn
Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
Am J Cardiol 87:1-6. 2001
..Thus, the MIR data showed no protective effects of preinfarction angina in patients with AMI treated with primary angioplasty...
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in R Zahn
Herzzentrum Ludwigshafen, Kardiologie, Germany
J Am Coll Cardiol 36:2064-71. 2000
..We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998...
Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery diseaseR Zahn
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Blood Coagul Fibrinolysis 13:81-7. 2002
..This association was significant only for men. It may indicate a contribution of the APC resistance to the development of CAD, which has to be proven by the follow-up...
[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]R Zhan
Herzzentrum Ludwigshafen, Kardiologie Bremserstrasse 79 67063 Ludwigshafen, Germany
Z Kardiol 91:49-57. 2002
..AMI patients treated with thrombolysis were more likely to be treated with either percutaneous coronary intervention or coronary bypass surgery after discharge...
Antibiotic therapy after acute myocardial infarction: a prospective randomized studyRalf Zahn
Kardiologie, Herzzentrum Ludwigshafen, Germany
Circulation 107:1253-9. 2003
..We investigated whether treatment with the macrolide antibiotic roxithromycin would reduce mortality or morbidity in patients with an acute myocardial infarction...
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry]Ralf Zahn
Herzzentrum, Kardiologie, Ludwigshafen
Herz 29:181-6. 2004
..Under the circumstances of frozen medical budgets in Germany, there may also be a shift toward implantation of a drug-eluting stent (DES) for indications not yet evaluated by RCTs...
Transcatheter aortic valve implantation: first results from a multi-centre real-world registryRalf Zahn
Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
Eur Heart J 32:198-204. 2011
..We report the first results of the prospective multi-centre German Transcatheter Aortic Valve Interventions-Registry...
Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study GroupR Zahn
Herzzentrum Ludwigshafen, Department of Cardiology, Germany
J Am Coll Cardiol 35:1820-6. 2000
..We describe the baseline characteristics and clinical course of patients who had an acute myocardial infarction (AMI) during their hospital stay...
Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA)Ralf Zahn
Department of Cardiology, Heart Center Ludwigshafen, Germany
Herz 28:445-52. 2003
..It remains unknown whether the ACT-prolonging effect of abciximab is clinically equivalent to a comparable degree of anti-coagulation by heparin...
Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume centerR Zahn
Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 92:438-44. 2003
..Its effectiveness in daily clinical practice in unselected patients remains to be determined...
Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioningRalf Zahn
Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
J Heart Valve Dis 20:64-9. 2011
..However, a potential problem of TAVI is the development of severe aortic insufficiency after valve implantation due to a too-low implantation of the valve...
Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registriesRalf Zahn
Herzzentrum Ludwigshafen, Kardiologie Bremserstrasse 79 67063 Ludwigshafen, Germany
Z Kardiol 91:64-71. 2002
..82, p < 0.0001) in the different subgroups, which showed an increasing absolute benefit of primary angioplasty compared to thrombolysis with increasing mortality risk...
Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registryK Donges
Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
Am J Cardiol 87:1039-44. 2001
..Thrombolysis is associated with a higher and beta blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity...
Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRM Gottwik
, , Germany
Eur Heart J 22:1794-801. 2001
....
Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registryMohamed Abdel-Wahab
Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany
Heart 97:899-906. 2011
..Following transcatheter aortic valve implantation (TAVI), AR is common, but little is known about its determinants and its effect on clinical outcome...
Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trialU Burkhardt
, , Bremserstr. 79, 67063 Ludwigshafen, Germany
Z Kardiol 93:671-8. 2004
..pneumoniae and treatment with roxithromycin did not influence these events, independently of the serostatus against C. pneumoniae. However, the power of this subgroup analysis was low to detect small but significant differences...
Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studiesB Frilling
Hezzentrum Ludwigshafen, Department of Cardiology, Bremserstr 79, 67063 Ludwigshafen, Germany
Am Heart J 141:200-5. 2001
..However, not all patients receive aspirin for AMI. The aim of this study was to provide information on characteristics and clinical course of patients not treated with aspirin for AMI...
Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)U Zeymer
Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 94:392-8. 2005
..The ALKK registry contains about 20% of the invasive and interventional cardiological procedures performed in Germany...
Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonistsB Mark
Herzzentrum Ludwigshafen, Kardiologie, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67073 Ludwigshafen, Germany
Z Kardiol 92:1018-24. 2003
..In addition to lesion characteristics, particularly stenting is associated with an increased rate of elevated troponin...
Two year follow-up in 643 patients with non-invasively unexplained syncope and therapy guided by electrophysiologic studyK Seidl
Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063 Ludwigshafen, Germany
Z Kardiol 92:852-61. 2003
..Although it has become standard practice to perform electrophysiologic studies in patients with unexplained syncope, limited information exists on prognosis after therapy guided by electrophysiologic studies...
Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practiceT Heer
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Heart 92:1484-9. 2006
..To assess the safety and effectiveness of abciximab in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in clinical practice...
Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry)Oliver Koeth
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Am J Cardiol 104:1074-7. 2009
..Hospital mortality in those patients is very high. Primary PCI improves the prognosis and is therefore the preferred reperfusion strategy in these patients...
Usefulness of a non-invasive scoring system in predicting the outcome of electrophysiologic studies in non-invasively unexplained syncopeK Seidl
Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063 Ludwigshafen, Germany
Z Kardiol 92:147-54. 2003
..However, it is invasive with possible procedure-related complications. Therefore, it would be helpful to identify patients in whom an electrophysiologic study is useful for diagnosis of syncope...
Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarctionUwe Zeymer
Herzzentrum Ludwigshafen, Medizinische Klinik B, Germany
Thromb Haemost 99:150-4. 2008
....
Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shockOliver Koeth
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Clin Res Cardiol 98:781-6. 2009
..The aim of our analysis is to assess gender differences in baseline characteristics, acute therapies, and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock...
Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardialUwe Zeymer
Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
Thromb Haemost 99:155-60. 2008
..This advantage was associated with an increase in major bleeding complications...
Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarctionTimm Bauer
Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Clin Cardiol 32:718-23. 2009
..Little is known about the influence of chronic antithrombotic therapy on treatment and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI)...
Coronary aneurysmsU Zeymer
Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063 Ludwigshafen, Germany
Z Kardiol 94:303-4. 2005
[In-stent-stenosis of a bare-metal stent 11 years after its implantation]A C Skarlos
Herzzentrum, Kardiologie, Klinikum Ludwigshafen
Dtsch Med Wochenschr 135:1067-70. 2010
..A balloon angioplasty of his left anterior descending artery had been performed 12 years ago and two bare-metal stents had been implanted two months later for an early restenosis...
Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratoriesPatricia Krüth
Herzzentrum, Med Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
Clin Res Cardiol 97:742-7. 2008
..However little is known about the impact of admission on weekend in hospitals with catheterisation laboratories...
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI TrialUwe Zeymer
Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
J Am Coll Cardiol 56:463-9. 2010
..The aim of this study was to compare eptifibatide and abciximab as adjuncts to primary percutaneous coronary intervention (PCI)...
Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarctionTimm Bauer
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
J Cardiovasc Pharmacol 53:132-6. 2009
..We sought to investigate the impact of prior statin therapy on in-hospital outcome in patients presenting with acute non-ST-elevation myocardial infarction...
[Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry]Uwe Zeymer
Medizinische Klinik B, Herzzentrum, Ludwigshafen
Herz 29:651-5. 2004
..The aim of the present prospective registry was to evaluate the efficacy and safety of eptifibatide in clinical practice...
Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA studyBirgit Frilling
Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
Am Heart J 148:306-11. 2004
..However, a significant number of patients do not receive aspirin after AMI. Little is known about why aspirin is withheld or the long-term outcome of these patients today...
Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome. Results of the MITRA plus registryOliver Koeth
Department of Cardiology, Herzzentrum Ludwigshafen, Klinikum Ludwigshafen, Bremserstr 79, 67063 Ludwigshafen am Rhein, Germany
Clin Res Cardiol 98:107-13. 2009
..Percutaneous coronary intervention (PCI) early after thrombolysis (early PCI) in patients with ST-elevation myocardial infarction (STEMI) is currently advised by clinical guidelines, but little is known about its use in clinical practice...
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende KUwe Zeymer
Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Eur Heart J 25:322-8. 2004
..Our results seen in connection with the results of the randomized SHOCK study advocate an early invasive approach in younger patients with cardiogenic shock, while the best strategy in elderly patients is still a matter of debate...
Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarctionUwe Zeymer
Herzzentrum Ludwigshafen, Medizinsche Klinik B, Ludwigshafen, Germany
Acute Card Care 10:43-8. 2008
..We sought to assess the effect of clopidogrel on one-year ischemic events in unselected patients with NSTEMI...
Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximabBirgit Frilling
Heart Center Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
Am J Cardiol 89:450-2. 2002
Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practiceUwe Zeymer
Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
Am J Cardiol 98:19-22. 2006
....
Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarctionTimm Bauer
Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
Eur Heart J 28:2873-8. 2007
..We sought to investigate the impact of an invasive treatment in elderly patients presenting with non-ST elevation myocardial infarction (NSTEMI) in clinical practice...
Evaluation of hospitals regarding outcomes and baseline risk -- an application to percutaneous coronary interventionMatthias Hochadel
Institut für Herzinfarktforschung, Bremserstrasse 79, 67063 Ludwigshafen am Rhein, Germany
Clin Res Cardiol 96:502-7. 2007
..55-5.44%). The outcome of seven centres differed significantly from the expectation. CONCLUSION: In comparisons of the outcome quality of hospitals, adjustment for the patients' baseline risk by an appropriate method is indispensable...
Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practiceUwe Zeymer
Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
Eur Heart J 27:2661-6. 2006
..We sought to assess the effect of clopidogrel on clinical events 1 year after discharge in survivors of ST-elevation myocardial infarction (STEMI) in clinical practice...
[Temporal trends in the use of drug-eluting stents in German clinical practice]Bärbel Klein
Medizinische Klinik B, Klinikum der Stadt Ludwigshafen, Herzzentrum, Ludwigshafen
Herz 33:450-4. 2008
..The following study is based on data of the ALKK PCI registry and assesses the use of DES depending on patient characteristics, indication and coronary status comparing the treatment years 2003 and 2005...
Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trialUwe Zeymer
Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
Eur Heart J 26:1971-7. 2005
..Little is known about the use of eptifibatide in this setting...
Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practiceTimm Bauer
Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, Ludwigshafen, Germany
Clin Res Cardiol 98:171-8. 2009
..However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events...
A rare manifestation of hypertrophic nonobstructive cardiomyopathy in a young patient without history of cardiac arrhythmiasJohannes Schwab
Medizinische Klinik 8, Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
Clin Res Cardiol 95:357-9. 2006
Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion StudyKarlheinz Seidl
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
J Am Coll Cardiol 39:1436-42. 2002
....
Clinical, angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathyOliver Koeth
Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Clin Res Cardiol 97:623-7. 2008
..The aim was to assess clinical, angiographic and cardiovascular magnetic resonance (CMR) findings in patients with Takotsubo cardiomyopathy...
Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry)Rajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 99:1288-93. 2007
..This low risk along with the less invasive nature of the procedure should make CAS an attractive and perhaps preferred option for the treatment of these patients...
Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vesselsRainer Hoffmann
aMedical Clinic I, University RWTH Aachen, Aachen, Germany
Coron Artery Dis 18:559-64. 2007
..Patients treated with SES for saphenous vein graft disease were compared with patients receiving SES in native vessel disease...
Drug-eluting stents: effective and safe for every patient and every lesion?Uwe Zeymer
Eur Heart J 28:2559-60. 2007
Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarctionRajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Interv Cardiol 21:8-14. 2008
..Whether the relatively lower dose results in lower effectiveness of fibrinolytic agents versus primary percutaneous coronary interventions (PCI) in patients with higher body mass index (BMI) is not known...
Catheter ablation of chronic atrial fibrillation with noncontact mapping: are continuous linear lesions associated with ablation success?Karlheinz Seidl
Department of Clinical Electrophysiology, Division of Cardiology, Heart Center Ludwigshafen, Germany
Pacing Clin Electrophysiol 26:534-43. 2003
..NCM identifies discontinuities in lines of ablation. Successful ablation of chronic AF is associated with continuity of linear lesions and good clinical technique demands a vigilant search for and closure of every gap...